A Company Review of IVAX Corporation Covering 40 Deals Made and Its Subsidiaries with 43 Partnering Companies

Business Wire, Nov 10, 2005

DUBLIN, Ireland -- Research and Markets (http://www.researchandmarkets.com/reports/c26870) has announced the addition of IVAX Corporation Deals Briefing to their offering

Description

IVAX Corporation Deals briefing provides an in-depth view of the 40 deals made by IVAX Corporation and its subsidiaries with 43 partnering companies between 2000 and 2005, in a clear and accessible PDF format.

Chapter 1: Company profile

An overview of the company, including contact details, a summary of business and partnering interests, and a review of management

Chapter 2: Financial data and deals overview

A summary of the company's financial status and overview of the numbers of deals by deal type, therapy focus, deal stage and industry sector.

Chapter 3: Summary of deals

A comprehensive overview listing deals by partner company, therapy focus and development stage, with a full index of all the deals announced.

Chapter 4: List of deals

A detailed listing of all the company's deals and alliances announced between January 2000 and July 2005.

Every deal is fully categorized, includes a detailed description, and includes financials such as headline value, upfront payments and royalty rates, where disclosed.

Scope

The report contains:

a brief company profile including subsidiary names

financial information where disclosed

a deals overview

specialized indexes including deals by partner company, subsidiary company, therapy focus and development stage

a detailed listing of the company's deals and alliances.

Key questions answered

IVAX Corporation Deals briefing provides a comprehensive summary of the deals and alliances announced by the company and its subsidiaries between January 2000 and July 2005. This report helps in:

identifying active partners

tracking competitor activity

benchmarking deals

comparing the finances of different deal types.

IVAX Corporation Deals briefing brings all relevant partnering deals into one place, providing a reference to deal making by IVAX Corporation.

Forecasts, projections, market estimates

This report provides: a financial summary table detailing the yearly total revenues, pharma revenues, R&D spend and profit of the company; and a series of tables detailing the number of deals made by deal type, by therapy focus, by development stage and by industry sector.

Who should buy the report

This report is essential reading for board and executive management, and individuals in:

business development

licensing/partnering

deal making

business strategy

marketing and promotion

distribution and manufacturing (including contract services).

Topics Covered

Introduction

About Partneringdesk Deals briefings

Chapter 1: Company profile

Chapter 2: Financial data and deals overview

Chapter 3: Summary of deals

Deals involving IVAX Corporation by partner company

Deals involving IVAX Corporation by subsidiary

Deals involving IVAX Corporation by therapy focus

Deals involving IVAX Corporation by development stage

Chapter 4: List of deals

Glossary

List of Tables

Table 2.1 IVAX Corporation financial summary

Table 2.2 IVAX Corporation deals by deal type

Table 2.3 IVAX Corporation deals by therapy focus

Table 2.4 IVAX Corporation deals by development stage

Table 2.5 IVAX Corporation deals by industry sector

Companies Mentioned

ChemSource Corporation, Indiana Protein Technologies Inc, IVAX Diagnostics Inc, Laboratorio Chile SA, Laboratorios Elmor SA, Laboratorios Fustery SA de CV, Netpharma Scandinavia AB, Novopharm, Wakefield Pharmaceuticals Inc, Zenith Goldline Pharmaceuticals

For more information visit http://www.researchandmarkets.com/reports/c26870